Lim Jonathan E
SEC CIK 1283290 · EDGAR
BoughtSold
Most active insiders at MAZE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bernstein Harold | Pres, CMO, R, D | — | $9.02M |
| 2 | Coloma Jason V | CEO, Dir | — | $5.25M |
| 3 | Dandekar Atul | CSBO | — | $5.01M |
| 4 | Bachrodt Amy | SVP, Fin | — | $1.56M |
| 5 | Sohn Catherine A. | Dir | — | $1.15M |
| 6 | Courtney Phillips | GC, Corp. Sec | — | $104.8K |
| 7 | Third Rock Ventures GP V, LP | 10% | — | — |
| 8 | HOMCY CHARLES J | Dir | — | — |
Lim Jonathan E made no open-market trades at MAZE in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-02-04 | 2025-02-03 | MAZE | Maze Therapeutics, Inc. | Lim Jonathan E | Dir | C - Cnv Deriv | — | +308.0K | 308.0K | New | — |
| DI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | Lim Jonathan E | Dir | C - Cnv Deriv | — | +525.3K | 550.9K | +2,049% | — |
| MI | 2023-12-06 | 2023-12-05+ | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $1.70 | +1.00M | 12.90M | +8% | +$1.70M |
| I | 2023-10-10 | 2023-10-05 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.03 | +1.00M | 19.46M | +5% | +$2.03M |
| I | 2023-06-08 | 2023-06-08 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.75 | +100.0K | 18.40M | +0.5% | +$275.0K |
| I | 2023-03-28 | 2023-03-28 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.84 | +100.0K | 18.30M | +0.5% | +$284.0K |
| I | 2023-01-10 | 2023-01-10 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $3.86 | +60.0K | 20.26M | +0.3% | +$231.6K |
| I | 2022-12-15 | 2022-12-14 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $4.99 | +40.0K | 20.20M | +0.2% | +$199.6K |
Purchase Sale Sale after option exercise All abbreviations